Abstract
This study analyses the internationalization characteristics of Large Brazilian Pharmaceutical Companies. It contributes to the international business and evolutionary literature by showing how the home country institutional environment affects the firms? internationalization at a country- and industry-level. The methodology is a multiple case study with eight companies, exploring their competitive advantages, strategies, and obstacles to international expansion. Findings reveal that home country institutional environment constraints pushed companies to build capabilities to survive and compete in the domestic market, which served as advantages when going international. Companies? internationalization is driven by the exploitation and exploration of assets and capabilities.
| Original language | English |
|---|---|
| Pages (from-to) | 333-362 |
| Number of pages | 30 |
| Journal | Latin American Business Review |
| Volume | 24 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published (VoR) - 2 Oct 2023 |
Funding
This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES) (Grant number 001), and the Ministry of Health through the National Council for Scientific and Technological Development (CNPq), as a partial result of the Project “Reflection of Brazilian Health Industrial and Technological Policies for Local Production and Supply of the Unified Health System (SUS)” (Grant number 41/2013).
| Funders | Funder number |
|---|---|
| Unified Health System | 41/2013 |
| Ministry of Health | |
| Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | 001 |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico |
Keywords
- emerging markets multinational enterprise
- home country institutional environment
- internationalisation drivers
- pharmaceutical industry
- Brazil.